tm
Seeing Is Believing
tm
Seeing Is Believing
OBIO is currently covered by 7 analysts with an average price target of $12.55. This is a potential upside of $6.85 (120.18%) from yesterday's end of day stock price of $5.7.
Orchestra BioMed Holdings's activity chart (see below) currently has 25 price targets and 35 ratings on display. The stock rating distribution of OBIO is 90% BUY and 10% HOLD.
Analysts average stock forecasts to be materialized ratio is 3.98% with an average time for these price targets to be met of 9.54 days.
Highest price target for OBIO is $20, Lowest price target is $9, average price target is $12.55.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 23-Oct-2026. First documented stock forecast 07-Feb-2023.
Currently out of the existing stock ratings of OBIO, 9 are a BUY (90%), 1 are a HOLD (10%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Feb-2023
$20
$14.32 (252.11%)
$20
17 days ago
(23-Oct-2026)
1/8 (12.5%)
$14.41 (257.78%)
57
Hold Since 10-Sep-2026
$10
$4.32 (76.06%)
1 months 30 days ago
(10-Sep-2026)
0/3 (0%)
$4.19 (72.12%)
Buy Since 24-Feb-2023
$10
$4.32 (76.06%)
$15
2 months 29 days ago
(11-Aug-2026)
1/4 (25%)
$5.6 (127.27%)
10
Buy Since 25-Jul-2024
$10
$4.32 (76.06%)
$15
5 months 21 days ago
(19-May-2026)
0/2 (0%)
$6 (150.00%)
Buy Since 22-Aug-2024
$10
$4.32 (76.06%)
$10
5 months 26 days ago
(14-May-2026)
0/7 (0%)
$5.89 (143.31%)
What is OBIO (Orchestra BioMed Holdings) average time for price targets to be met?
Which analyst most recently updated their price target on OBIO (Orchestra BioMed Holdings)?
Which analyst has the most public recommendations on OBIO (Orchestra BioMed Holdings)?
Which analyst is the currently most bullish on OBIO (Orchestra BioMed Holdings)?
Which analyst is the currently most reserved on OBIO (Orchestra BioMed Holdings)?
